尾原 秀明

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Living Donors 82%
3. Aneurysm 62%
4. Transplants 61%
5. Acute Liver Failure 38%
6. Liver 37%
7. Transplantation 30%
8. Abdominal Aortic Aneurysm 28%
9. Iliac Artery 28%
10. Stents 26%
11. Tissue Donors 22%
12. Superior Mesenteric Artery 20%
13. Surgical Wound Infection 18%
14. Uterus 18%
15. Macaca 16%
16. Allografts 15%
17. Splenic Artery 15%
18. Arteries 14%
19. Endoleak 14%
20. Reperfusion Injury 13%
21. Extremities 13%
22. Therapeutics 12%
23. olanexidine 12%
24. Japan 12%
25. Biliary Atresia 12%
26. High Mobility Group Proteins 12%
27. Infections 11%
28. HMGB1 Protein 11%
29. Portal Vein 11%
30. Acute Abdomen 10%
31. Hepatocytes 10%
32. Interleukin-1 Receptors 10%
33. Swine 9%
34. Primates 9%
35. Homologous Transplantation 9%
36. Artificial Liver 9%
37. Incidence 9%
38. Natural Killer Cells 8%
39. Immunosuppression 8%
40. Pathologic Constriction 8%
41. Ischemia 8%
42. Mortality 8%
43. Liver Failure 8%
44. Antibodies 8%
45. Practice Guidelines 7%
46. Equipment and Supplies 7%
47. Povidone-Iodine 7%
48. Peripheral Arterial Disease 7%
49. Cohort Studies 7%
50. Liver Regeneration 7%